학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 17건 | 목록 1~20
Academic Journal
Aitken, S J, Anderson, C J, Connor, F, Pich, O, Sundaram, V, Feig, C, Rayner, T F, Lukk, M, Aitken, S, Luft, J, Kentepozidou, E, Arnedo-Pac, C, Beentjes, S V, Davies, S E, Drews, R M, Ewing, A, Kaiser, V B, Khamseh, A, Lopez-Arribillaga, E, Redmond, A M, Santoyo-Lopez, J, Sentís, I, Talmane, L, Yates, A D, Semple, C A, López-Bigas, N, Flicek, P, Odom, D T & Taylor, M S 2020, ' Pervasive lesion segregation shapes cancer genome evolution ', Nature, vol. 583, pp. 265–270 . https://doi.org/10.1038/s41586-020-2435-1
Nature
Academic Journal
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname
Academic Journal
Solé L; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Lobo-Jarne T; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Álvarez-Villanueva D; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Alonso-Marañón J; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Guillén Y; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Guix M; Department of Oncology, Institut Mar d'Investigacions Mèdiques, CIBERONC, Universitat Pompeu Fabra, Barcelona, 08003, Spain.; Sangrador I; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Rozalén C; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Vert A; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Barbachano A; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Cancer Biology, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.; Lop J; Department of Pathology, Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona, Barcelona, 08003, Spain.; Salido M; Department of Pathology, Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona, Barcelona, 08003, Spain.; Bellosillo B; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona, Barcelona, 08003, Spain.; García-Romero R; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Garrido M; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; González J; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Martínez-Iniesta M; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; López-Arribillaga E; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Group of Biomedical Genomics, Institut de Recerca Biomedica (IRB), Barcelona, 08028, Spain.; Salazar R; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Montagut C; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Oncology, Institut Mar d'Investigacions Mèdiques, CIBERONC, Universitat Pompeu Fabra, Barcelona, 08003, Spain.; Torres F; Biostatistics Unit, Medical School, Universitat Autònoma de Barcelona, Barcelona, Spain.; Iglesias M; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona, Barcelona, 08003, Spain.; Celià-Terrassa T; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain.; Muñoz A; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Cancer Biology, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.; Villanueva A; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Bigas A; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain. abigas@imim.es.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. abigas@imim.es.; Espinosa L; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, 08003, Spain. lespinosa@imim.es.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. lespinosa@imim.es.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Sentís I; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Gonzalez S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Barcelona Institute of Science and Technology (BIST), Baldiri i Reixac 10, 08028, Barcelona, Spain.; Genescà E; Hematology Departments, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; García-Hernández V; Program in Cancer Research, Institut Hospital del Mar d'Investigacions Mèdiques, CIBERONC, Barcelona, Spain.; Muiños F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Gonzalez C; Hematology Departments, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; López-Arribillaga E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Gonzalez J; Program in Cancer Research, Institut Hospital del Mar d'Investigacions Mèdiques, CIBERONC, Barcelona, Spain.; Fernandez-Ibarrondo L; Pathology Department, CIBERONC, Hospital del Mar, IMIM, Barcelona, Spain.; Mularoni L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; CMR[B] Center of Regenerative Medicine, Barcelona, Spain.; Espinosa L; Program in Cancer Research, Institut Hospital del Mar d'Investigacions Mèdiques, CIBERONC, Barcelona, Spain.; Bellosillo B; Pathology Department, CIBERONC, Hospital del Mar, IMIM, Barcelona, Spain.; Ribera JM; Hematology Departments, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain. jribera@iconcologia.net.; Bigas A; Program in Cancer Research, Institut Hospital del Mar d'Investigacions Mèdiques, CIBERONC, Barcelona, Spain. abigas@imim.es.; Gonzalez-Perez A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Lopez-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. nuria.lopez@irbbarcelona.org.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain. nuria.lopez@irbbarcelona.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. nuria.lopez@irbbarcelona.org.
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE
Academic Journal
Marruecos L; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.; Bertran J; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.; Faculty of Science and Technology, Bioinformatics and Medical Statistics Group, University of Vic-Central University of Catalonia, Vic, Spain.; Guillén Y; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.; González J; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.; Batlle R; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Barcelona, Spain.; López-Arribillaga E; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.; Garrido M; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.; Ruiz-Herguido C; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.; Lisiero D; The McArdle Laboratory of Cancer Research, University of Wisconsin, Madison, WI, USA.; Department of Oncology, University of Wisconsin, Madison, WI, USA.; González-Farré M; Department of Pathology, CIBERONC, University Autonomous of Barcelona, Hospital del Mar, Barcelona, Spain.; Arce-Gallego S; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.; Iglesias M; Department of Pathology, CIBERONC, University Autonomous of Barcelona, Hospital del Mar, Barcelona, Spain.; Nebreda AR; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Barcelona, Spain.; ICREA, Barcelona, Spain.; Miyamoto S; The McArdle Laboratory of Cancer Research, University of Wisconsin, Madison, WI, USA.; Department of Oncology, University of Wisconsin, Madison, WI, USA.; Bigas A; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.; Espinosa L; Cancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-3178 (Electronic) Linking ISSN: 1469221X NLM ISO Abbreviation: EMBO Rep Subsets: MEDLINE
Academic Journal
López-Arribillaga E; Cancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Rodilla V; Cancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Colomer C; Cancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Vert A; Cancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Shelton A; Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.; Cheng JH; Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.; Yan B; Cancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Gonzalez-Perez A; Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute and Universitat Pompeu Fabra, Doctor Aiguader 88, 08003, Barcelona, Catalonia, Spain.; Junttila MR; Department of Translational Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.; Iglesias M; Department of Pathology, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Universitat Autonoma of Barcelona, Barcelona, 08193, Spain.; Torres F; Universitat Autonoma of Barcelona, Barcelona, 08193, Spain.; Albanell J; Cancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Department of Oncology, Hospital del Mar, CIBERONC. Doctor Aiguader 88, 08003, Barcelona, Spain.; Villanueva A; Laboratori de Recerca Translacional, IDIBELL-Institut Català d'Oncologia Gran Via km 2.7, Hospitalet, 08907, Barcelona, Spain.; Bigas A; Cancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain. abigas@imim.es.; Siebel CW; Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. siebel.christian@gene.com.; Espinosa L; Cancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain. lespinosa@imim.es.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
López-Arribillaga E; Stem Cells and Cancer Research Laboratory, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), CIBERONC, 08003 Barcelona, Spain.; Yan B; Stem Cells and Cancer Research Laboratory, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), CIBERONC, 08003 Barcelona, Spain.; Lobo-Jarne T; Stem Cells and Cancer Research Laboratory, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), CIBERONC, 08003 Barcelona, Spain.; Guillén Y; Stem Cells and Cancer Research Laboratory, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), CIBERONC, 08003 Barcelona, Spain.; Menéndez S; Departament of Oncology, Hospital del Mar, 08003 Barcelona, Spain.; Andreu M; Gastroenterology Department, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.; Bigas A; Stem Cells and Cancer Research Laboratory, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), CIBERONC, 08003 Barcelona, Spain.; Iglesias M; Departament of Pathology, Hospital del Mar, CIBERONC, 08003 Barcelona, Spain.; Espinosa L; Stem Cells and Cancer Research Laboratory, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), CIBERONC, 08003 Barcelona, Spain.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE
Academic Journal
Martínez-Jiménez F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Muiños F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; López-Arribillaga E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Lopez-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. nuria.lopez@irbbarcelona.org.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain. nuria.lopez@irbbarcelona.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. nuria.lopez@irbbarcelona.org.; Gonzalez-Perez A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. abel.gonzalez@irbbarcelona.org.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain. abel.gonzalez@irbbarcelona.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Editorial & Opinion
López-Arribillaga E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science & Technology (BIST), Barcelona, Spain.; Rodilla V; Preclinical Research Program, Vall d'Hebron Institute of Oncology, CIBERONC, Barcelona, Spain.; Espinosa L; Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Doctor Aiguader 88, Barcelona 08003, Spain.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol
Academic Journal
Gallardo F; Dermatology Department, Parc de Salut Mar-Hospital del Mar, Barcelona, Spain.; Bertran J; Faculty of Sciences and Technology, Bioinformatics and Medical Statistics Group, University of Vic - Central University of Catalonia, 08500, Vic, Spain.; López-Arribillaga E; Stem Cells and Cancer Research Laboratory, CIBERONC, Institut Hospital del Mar Investigacions Mèdiques (IMIM), 08003, Barcelona, Spain.; González J; Stem Cells and Cancer Research Laboratory, CIBERONC, Institut Hospital del Mar Investigacions Mèdiques (IMIM), 08003, Barcelona, Spain.; Menéndez S; Molecular Therapy of Cancer Group, Parc de Salut Mar-Hospital del Mar, 08003, Barcelona, Spain.; Sánchez I; Pathology Department, Parc de Salut Mar-Hospital del Mar, Barcelona, Spain.; Colomo L; Pathology Department, Parc de Salut Mar-Hospital del Mar, Barcelona, Spain.; Iglesias M; Pathology Department, Parc de Salut Mar-Hospital del Mar, Barcelona, Spain.; Garrido M; Stem Cells and Cancer Research Laboratory, CIBERONC, Institut Hospital del Mar Investigacions Mèdiques (IMIM), 08003, Barcelona, Spain.; Santamaría-Babí LF; Translational Immunology, Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.; Torres F; Biostatistics and Data Management Platform, IDIBAPS, Hospital Clínic, Biostatistics Unit. Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Pujol RM; Dermatology Department, Parc de Salut Mar-Hospital del Mar, Barcelona, Spain.; Bigas A; Stem Cells and Cancer Research Laboratory, CIBERONC, Institut Hospital del Mar Investigacions Mèdiques (IMIM), 08003, Barcelona, Spain. abigas@imim.es.; Espinosa L; Stem Cells and Cancer Research Laboratory, CIBERONC, Institut Hospital del Mar Investigacions Mèdiques (IMIM), 08003, Barcelona, Spain. lespinosa@imim.es.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Mulero MC; Program in Cancer Research, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona 08003, Spain.; Ferres-Marco DIslam AMargalef PPecoraro MToll ADrechsel NCharneco CDavis SBellora NGallardo FLópez-Arribillaga EAsensio-Juan ERodilla VGonzález JIglesias MShih VMar Albà MDi Croce LHoffmann AMiyamoto SVillà-Freixa JLópez-Bigas NKeyes WMDomínguez MBigas AEspinosa L
Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Academic Journal
López-Arribillaga E; Program in Cancer Research, IMIM-Hospital del Mar, Barcelona 08003, Spain.; Rodilla V; Program in Cancer Research, IMIM-Hospital del Mar, Barcelona 08003, Spain.; Pellegrinet L; Ecole Polytechnique Federale de Lausanne, Lausanne 1015, Switzerland.; Guiu J; Program in Cancer Research, IMIM-Hospital del Mar, Barcelona 08003, Spain.; Iglesias M; Department of Pathology, Hospital del Mar, Barcelona 08003, Spain.; Roman AC; Department of Biochemistry and Molecular Biology, University of Extremadura, Badajoz 06071, Spain.; Gutarra S; Departament de Ciències Experimentals, Universitat Pompeu Fabra, Barcelona 08003, Spain.; González S; Stem Cell Aging Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain.; Muñoz-Cánoves P; Departament de Ciències Experimentals, Universitat Pompeu Fabra, Barcelona 08003, Spain Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08003, Spain.; Fernández-Salguero P; Department of Biochemistry and Molecular Biology, University of Extremadura, Badajoz 06071, Spain.; Radtke F; Ecole Polytechnique Federale de Lausanne, Lausanne 1015, Switzerland.; Bigas A; Program in Cancer Research, IMIM-Hospital del Mar, Barcelona 08003, Spain abigas@imim.es lespinosa@imim.es.; Espinosa L; Program in Cancer Research, IMIM-Hospital del Mar, Barcelona 08003, Spain abigas@imim.es lespinosa@imim.es.
Publisher: Company Of Biologists Limited Country of Publication: England NLM ID: 8701744 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-9129 (Electronic) Linking ISSN: 09501991 NLM ISO Abbreviation: Development Subsets: MEDLINE
Book
In: Targeting Notch in Cancer: From the Fruit Fly to the Clinic. (Targeting Notch in Cancer: From the Fruit Fly to the Clinic, 23 November 2018, :333-352)
검색 결과 제한하기
제한된 항목
[검색어] López-Arribillaga, E.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어